Operating Income for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current operating income (TTM) is $1.82B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$1.82B
YoY change
+27.7%
5Y CAGR
+15.8%
Peak year (2025)
$1.69B
Cumulative operating income
$11.67B
Operating Income history chart for ResMed (RMD) from 1993 to 2025
Operating Income history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $1.69B | +27.7% | ||
| 2024 | $1.32B | +16.6% | ||
| 2023 | $1.13B | +13.2% | ||
| 2022 | $1.00B | +10.7% | ||
| 2021 | $903.68M | +11.6% | ||
| 2020 | $809.66M | +39.8% | ||
| 2019 | $579.26M | +6.9% | ||
| 2018 | $541.83M | +27.3% | ||
| 2017 | $425.80M | -0.7% | ||
| 2016 | $428.95M | +4.8% | ||
| 2015 | $409.24M | +1.0% | ||
| 2014 | $405.09M | +14.2% | ||
| 2013 | $354.82M | +20.5% | ||
| 2012 | $294.41M | +10.3% | ||
| 2011 | $266.92M | +11.0% | ||
| 2010 | $240.38M | +26.3% | ||
| 2009 | $190.31M | +33.1% | ||
| 2008 | $142.97M | +58.6% | ||
| 2007 | $90.16M | -31.3% | ||
| 2006 | $131.30M | +34.9% | ||
| 2005 | $97.35M | +14.0% | ||
| 2004 | $85.36M | +26.9% | ||
| 2003 | $67.24M | -231.4% | ||
| 2002 | -$51.16M | -296.4% | ||
| 2001 | $26.04M | -21.4% | ||
| 2000 | $33.14M | +31.0% | ||
| 1999 | $25.30M | +46.2% | ||
| 1998 | $17.30M | +108.4% | ||
| 1997 | $8.30M | +124.3% | ||
| 1996 | $3.70M | +32.1% | ||
| 1995 | $2.80M | +115.4% | ||
| 1994 | $1.30M | +85.7% | ||
| 1993 | $700,000 | — |
Operating Income values are taken from ResMed's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual operating income for ResMed (RMD) came in at $1.69B – grew 27.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, ResMed operating income compounded at +15.8% per year, sustaining 8 straight years of year-over-year growth.
The highest annual operating income of $1.69B was reported in 2025. The lowest in the available history was -$51.16M in 2002.
ResMed (RMD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $22.84B.
ResMed Operating Income by Year
ResMed Operating Income 2025: $1.69B
ResMed operating income in 2025 was $1.69B, grew 27.7% from 2024. This figure represents the highest annual value in the available history.
ResMed Operating Income 2024: $1.32B
ResMed operating income in 2024 was $1.32B, grew 16.6% from 2023.
ResMed Operating Income 2023: $1.13B
ResMed operating income in 2023 was $1.13B, grew 13.2% from 2022.
ResMed Operating Income 2022: $1.00B
ResMed operating income in 2022 was $1.00B, grew 10.7% from 2021.
ResMed Operating Income 2021: $903.68M
ResMed operating income in 2021 was $903.68M.
See more financial history for ResMed (RMD).
Sector peers — Operating Income
Companies in the same sector as ResMed, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is ResMed's operating income?
- Latest reported operating income for ResMed (RMD) is $1.82B (period ending December 31, 2025).
How has ResMed operating income changed year-over-year?
- ResMed (RMD) operating income changed +27.7% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed operating income?
- ResMed (RMD) operating income compound annual growth rate is +15.8% over the most recent 5 years available.
When did ResMed operating income hit its highest annual value?
- ResMed operating income reached its highest annual value of $1.69B in 2025.
What was ResMed operating income in 2024?
- ResMed (RMD) operating income in 2024 was $1.32B.
What was ResMed operating income in 2025?
- ResMed (RMD) operating income in 2025 was $1.69B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.